Literature DB >> 33839890

Optimal definition of coagulation syndrome after colorectal endoscopic submucosal dissection: a post hoc analysis of randomized controlled trial.

Takahito Katano1, Takaya Shimura2, Satoshi Nomura1,3, Tomohiro Iwai4, Yusuke Mizuno5, Tomonori Yamada5, Masahide Ebi6, Yoshikazu Hirata7, Hirotada Nishie1, Takashi Mizushima8, Yu Nojiri1,9, Shozo Togawa9, Hiroki Koguchi10, Shunsuke Shibata4, Noriyuki Hayashi7, Keisuke Itoh11, Hiromi Kataoka1.   

Abstract

PURPOSE: Endoscopic clipping closure after colorectal endoscopic submucosal dissection (ESD) did not reduce the incidence of post-ESD coagulation syndrome (PECS) in our recent randomized controlled trial (RCT); however, the definition of PECS is still controversial. The aim of this study is to establish optimal definition of PECS with additional analysis of RCT based on another definition.
METHODS: In this multicenter, single-blind RCT, individuals were randomly assigned to colorectal ESD followed by endoscopic clipping closure or non-closure. In this post hoc analysis, the definition of PECS was modified as both localized abdominal pain on visual analogue scale and inflammatory response (fever or leukocytosis), from either localized abdominal pain or inflammatory response in the original study. All participants underwent a computed tomography after ESD, and PECS was classified into type I, conventional PECS without extra-luminal air, and type II, PECS with peri-luminal air.
RESULTS: A total of 155 patients (84 in the non-closure group and 71 in the closure group) were analyzed. As a result of criteria modification, 21 type I PECS and four type II PECS cases in the original study, which included patients with clear pain and inflammatory response, were downgraded to no adverse event and simple peri-luminal air, respectively. The frequency of PECS showed no significant difference between non-closure and closure groups.
CONCLUSION: Clipping closure after colorectal ESD does not reduce the incidence of PECS regardless of the diagnostic criteria. Either localized abdominal pain or inflammatory response might be optimal criteria of PECS (UMIN000027031). TRIAL REGISTRATION NUMBER: UMIN000027031 DATE OF REGISTRATION: April 18, 2017.

Entities:  

Keywords:  Clip; Coagulation syndrome; Colorectal tumor; Endoscopic submucosal dissection; Randomized controlled trial

Year:  2021        PMID: 33839890     DOI: 10.1007/s00384-021-03921-x

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  16 in total

1.  A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissections (with video).

Authors:  Yutaka Saito; Toshio Uraoka; Yuichiro Yamaguchi; Kinichi Hotta; Naoto Sakamoto; Hiroaki Ikematsu; Masakatsu Fukuzawa; Nozomu Kobayashi; Junichirou Nasu; Tomoki Michida; Shigeaki Yoshida; Hisatomo Ikehara; Yosuke Otake; Takeshi Nakajima; Takahisa Matsuda; Daizo Saito
Journal:  Gastrointest Endosc       Date:  2010-10-27       Impact factor: 9.427

2.  Long-term outcomes after endoscopic submucosal dissection for superficial colorectal tumors.

Authors:  Kenjiro Shigita; Shiro Oka; Shinji Tanaka; Kyoku Sumimoto; Daiki Hirano; Yuzuru Tamaru; Yuki Ninomiya; Naoki Asayama; Nana Hayashi; Fumio Shimamoto; Koji Arihiro; Kazuaki Chayama
Journal:  Gastrointest Endosc       Date:  2016-07-27       Impact factor: 9.427

3.  Utility of multi-detector computed tomography scans after colorectal endoscopic submucosal dissection: a prospective study.

Authors:  Ryosuke Kobayashi; Kingo Hirasawa; Chiko Sato; Makomo Makazu; Hiroaki Kaneko; Ryosuke Ikeda; Takehide Fukuchi; Atsushi Sawada; Yuichiro Ozeki; Masataka Taguri; Shigeo Takebayashi; Shin Maeda
Journal:  Gastrointest Endosc       Date:  2017-11-06       Impact factor: 9.427

4.  Line-assisted complete closure for a large mucosal defect after colorectal endoscopic submucosal dissection decreased post-electrocoagulation syndrome.

Authors:  Yasushi Yamasaki; Yoji Takeuchi; Taro Iwatsubo; Minoru Kato; Kenta Hamada; Yusuke Tonai; Noriko Matsuura; Takashi Kanesaka; Takeshi Yamashina; Masamichi Arao; Sho Suzuki; Satoki Shichijo; Hiroko Nakahira; Tomofumi Akasaka; Noboru Hanaoka; Koji Higashino; Noriya Uedo; Ryu Ishihara; Hiroyuki Okada; Hiroyasu Iishi
Journal:  Dig Endosc       Date:  2018-04-29       Impact factor: 7.559

5.  Effect of prophylactic closure on adverse events after colorectal endoscopic submucosal dissection: A meta-analysis.

Authors:  Mingqing Liu; Yangyu Zhang; Yueqi Wang; He Zhu; Hong Xu
Journal:  J Gastroenterol Hepatol       Date:  2020-07-05       Impact factor: 4.029

6.  Hospital volume and the occurrence of bleeding and perforation after colorectal endoscopic submucosal dissection: analysis of a national administrative database in Japan.

Authors:  Hiroyuki Odagiri; Hideo Yasunaga; Hiroki Matsui; Kiyohide Fushimi; Toshiro Iizuka; Mitsuru Kaise
Journal:  Dis Colon Rectum       Date:  2015-06       Impact factor: 4.585

7.  Endoscopic submucosal dissection in large sessile lesions of the rectosigmoid: learning curve in a European center.

Authors:  A Probst; D Golger; M Anthuber; B Märkl; H Messmann
Journal:  Endoscopy       Date:  2012-04-23       Impact factor: 10.093

8.  Prevalence and clinical features of coagulation syndrome after endoscopic submucosal dissection for colorectal neoplasms.

Authors:  Mi Jin Hong; Jeong Hwan Kim; Sun-Young Lee; In-Kyung Sung; Hyung Seok Park; Chan Sup Shim
Journal:  Dig Dis Sci       Date:  2014-12-13       Impact factor: 3.199

9.  Features of electrocoagulation syndrome after endoscopic submucosal dissection for colorectal neoplasm.

Authors:  Takeshi Yamashina; Yoji Takeuchi; Noriya Uedo; Kenta Hamada; Kenji Aoi; Yasushi Yamasaki; Noriko Matsuura; Takashi Kanesaka; Tomofumi Akasaka; Sachiko Yamamoto; Noboru Hanaoka; Koji Higashino; Ryu Ishihara; Hiroyasu Iishi
Journal:  J Gastroenterol Hepatol       Date:  2016-03       Impact factor: 4.029

10.  Risk factors of post-endoscopic submucosal dissection electrocoagulation syndrome for colorectal neoplasm.

Authors:  Sayo Ito; Kinichi Hotta; Kenichiro Imai; Yuichiro Yamaguchi; Yoshihiro Kishida; Kohei Takizawa; Naomi Kakushima; Masaki Tanaka; Noboru Kawata; Masao Yoshida; Hirotoshi Ishiwatari; Hiroyuki Matsubayashi; Hiroyuki Ono
Journal:  J Gastroenterol Hepatol       Date:  2018-06-26       Impact factor: 4.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.